Augmentation of antiproteinuric effect by combined therapy with angiotensin II receptor blocker plus calcium channel blocker in a hypertensive patient with IgA glomerulonephritis.
作者： S Kuriyama , H Tomonari , A Abe , T Kunieda , T Hosoya
关键词:
摘要: Augmentation of antiproteinuric effect by combined therapy with angiotensin II receptor blocker plus calcium channel in a hypertensive patient IgA glomerulonephritis
nature.com
sci-hub.se 参考文章(24)
Lawrence G. Hunsicker, , Sharon Adler, Arlene Caggiula, Brian K. England, Tom Greene, John W. Kusek, Nancy L. Rogers, Paul E. Teschan, Gerald Beck, Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study Kidney International. ,vol. 51, pp. 1908- 1919 ,(1997) , 10.1038/KI.1997.260
Akiko Imamura, Harald S. Mackenzie, Eric R. Lacy, Florence N. Hutchison, Wayne R. Fitzgibbon, David W. Ploth, Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats. Kidney International. ,vol. 47, pp. 1394- 1402 ,(1995) , 10.1038/KI.1995.196
Satoru Kuriyama, Haruo Tomonari, Aya Abe, Toshiyuki Imasawa, Tatsuo Hosoya, Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy. Nephron. ,vol. 86, pp. 529- 530 ,(2000) , 10.1159/000045855
George L. Bakris, Martha Siomos, Dejuran Richardson, Imke Janssen, W. Kline Bolton, Lee Hebert, Rajiv Agarwal, Daniel Catanzaro, ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure Kidney International. ,vol. 58, pp. 2084- 2092 ,(2000) , 10.1111/J.1523-1755.2000.00381.X
Yoshihiko Kakinuma, Tetsuya Kawamura, Teresa Bills, Toshimasa Yoshioka, Iekuni Ichikawa, Agnes Fogo, Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure Kidney International. ,vol. 42, pp. 46- 55 ,(1992) , 10.1038/KI.1992.259
Domenico Russo, Roberto Minutolo, Antonio Pisani, Raffaela Esposito, Giuseppe Signoriello, Michele Andreucci, Mario M. Balletta, Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy American Journal of Kidney Diseases. ,vol. 38, pp. 18- 25 ,(2001) , 10.1053/AJKD.2001.25176
Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke, Tomas Berl, Marc A. Pohl, Julia B. Lewis, Eberhard Ritz, Robert C. Atkins, Richard Rohde, Itamar Raz, Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes The New England Journal of Medicine. ,vol. 345, pp. 851- 860 ,(2001) , 10.1056/NEJMOA011303
Valentina Kon, Agnes Fogo, Iekuni Ichikawa, Samuel E. Hellings, Teresa Bills, Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition Kidney International. ,vol. 44, pp. 545- 550 ,(1993) , 10.1038/KI.1993.279
Domenico Russo, Antonio Pisani, Mario M. Balletta, Luca De Nicola, Francesco A. Savino, Michele Andreucci, Roberto Minutolo, Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy American Journal of Kidney Diseases. ,vol. 33, pp. 851- 856 ,(1999) , 10.1016/S0272-6386(99)70416-6
C. E. Mogensen, S. Neldam, I. Tikkanen, S. Oren, R. Viskoper, R. W Watts, M. E Cooper, Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study BMJ. ,vol. 321, pp. 1440- 1444 ,(2000) , 10.1136/BMJ.321.7274.1440